Penetration of cefuroxime axetil(CXM-AX) into oral tissues.
スポンサーリンク
概要
- 論文の詳細を見る
Objective : For the evaluation of the usefulness of Cefuroxime axetil (CXM-AX), a new oral Cephem antibiotic, in the field of Oral Surgery, oral tissue levels of CXM were determined and pharmacokinetic analysis was carried out.<BR>Method : CXM-AX in the dose of 30mg/kg was orally given to a total of 18 W istar strain rats (in 6 groups, each consisting of 3) through a gastric tube. Samples were taken at 15mins, 30 mins, lhr, 2hrs, 4hrs, and 6hrs after administration. In addition to the oral tissue samples from gingiva, tongue, mandibular bone, cervical lympho node and submandibular gland, serum, liver, and kidney samples were also taken for comparison. CXM levels were determined by bioassay, and a paper disc method was adopted using <I>Bacillus subtilis</I> ATCC 6633 as a test organism.<BR>Results : In serum, Tmax was 1.0 hr, Cmax, 6.95μg/ml and AUC, 24.93μg/hr/ml. When the tissue levels were compared among organs based on Cmax, the level was the highest in the kidney, and then in the descending order of liver, serum, cervical lymphonode, submandibular gland, tongue, gingiva and mandibular bone. The ratios of the above tissue levels to serum level were 1.62, 1.35, 0.78, 0.62, 0.50, 0.42 and 0.27, respectively.
- 日本歯科薬物療法学会の論文
日本歯科薬物療法学会 | 論文
- カンジダのバイオフィルム産生性に対する抗真菌薬の効果
- 当院における全身麻酔下手術中に使用された抗菌薬の15年間(1992-2006年)の推移
- 「顎骨骨髄炎に対する抗菌薬の効果判定基準」の解析結果
- 植物精油の口腔微生物に対する抗菌性およびバイオフィルム形成抑制効果の検討
- ニフェジピン歯肉増殖症患者の線維芽細胞に対する18α-グリチルレチン酸のアポトーシス誘導効果